Aclarubicin Hydrochloride API Manufacturer & Supplier in India

Aclarubicin Hydrochloride is a pharmaceutical-grade Active Pharmaceutical Ingredient in the Oncology / Anthracycline Antineoplastic Antibiotic category. Mediocon Inc supplies high-purity Aclarubicin Hydrochloride API (CAS 75443-99-1) from our GMP-certified facility in Aurangabad, Maharashtra, India. We cater to pharmaceutical manufacturers, formulators, and research organizations worldwide.

Aclarubicin Hydrochloride is primarily associated with: Hydrochloride salt of the anthracycline antibiotic aclarubicin. Mediocon's Aclarubicin Hydrochloride meets the highest pharmacopoeial standards and is manufactured under WHO-GMP compliant conditions for consistent quality and purity.

Key Features

• High-purity pharmaceutical grade API (NLT 95.0% assay)
• Pharma Grade / Injectable Oncology API compliant with full analytical verification
• Full CoA, MSDS/SDS, and COO documentation with every batch
• GMP certified manufacturing under ISO 9001:2015 QMS

Applications & Therapeutic Uses

• Acute myeloid leukaemia and other haematologic malignancies
• Injectable oncology formulation manufacturing
• Combination chemotherapy regimens
• Oncology generic drug development

Why Choose Mediocon

• ISO 9001:2015 & WHO-GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF support
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings (FDA, EMA, WHO)

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Aclarubicin Hydrochloride (CAS 75443-99-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Aclarubicin Hydrochloride is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (Pharma Grade / Injectable Oncology API). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

• USA — FDA-registered facility; DMF support available for ANDA/NDA filings
• Europe — EMA-compliant documentation; CEP/EDMF support on request
• Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
• Southeast Asia — established logistics network; temperature-controlled shipments
• India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

• ISO 9001:2015 certified quality management system
• GMP-certified manufacturing facility, Aurangabad, Maharashtra
• Full batch traceability from raw material to finished API
• Stability data available (ICH Q1A guidelines) for regulatory submissions
• Dedicated QA team for customer audits and regulatory queries